Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Here's Why AVEO Oncology Fell as Much as 12.7% Today
Here's Why AVEO Oncology Fell as Much as 12.7% Today
Here's Why AVEO Oncology Fell as Much as 12.7% Today
Submitted by
admin
on July 11, 2017 - 11:51pm
Source:
Motley Fool
News Tags:
Aveo Oncology
tivozanib
renal cell carcinoma
Headline:
Here's Why AVEO Oncology Fell as Much as 12.7% Today
Do Not Allow Advertisers to Use My Personal information
